X0306 4 2017-11-13 0 0001619087 SteadyMed Ltd. STDY 0001636975 Nassif David W. C/O STEADYMED THERAPEUTICS, INC. 2603 CAMINO RAMON, SUITE 350 SAN RAMON CA 94583 0 1 0 0 EVP and CFO Ordinary Shares 2017-11-13 4 A 0 44315 0.00 A 44315 D Each restricted stock unit represents a contingent right to receive one share of SteadyMed Ltd. ordinary shares. RSU shall vest in two tranches. On June 30, 2018, 22,158 shall vest. Thereafter, on the date that the New Drug Application for Trevyent is approved by the U.S. Food and Drug Administration, the remaining balance of 22,157 shares shall vest. /s/ David W. Nassif 2017-11-15